Abortion Coverage Is Limited or Unavailable at a Quarter of Large Workplaces
A KFF survey of employer health benefits shows that 28% of large U.S. companies have limited or no access to abortion under company health insurance.
The independent source for health policy research, polling, and news.
21-40 of 92 results
A KFF survey of employer health benefits shows that 28% of large U.S. companies have limited or no access to abortion under company health insurance.
The first Republican presidential debate of the 2024 cycle took place without front-runner Donald Trump — and with hardly a mention of health issues save for abortion. Meanwhile, in Florida, patients dropped from the Medicaid program are suing the state for not giving them enough notice or a way to contest their being dropped from the program. Margot Sanger-Katz of The New York Times, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.
It’s been a year since the Supreme Court overturned Roe v. Wade and, with it, the nationwide right to abortion. The decision in Dobbs v. Jackson Women’s Health Organization set off widespread uncertainty in government and the courts about the legality or illegality of the procedure. But the decision has had other consequences too, including affecting where health professionals choose to locate. In this special episode of KFF Health News’ “What the Health?” Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF’s Alina Salganicoff about the organization’s research and other work on women’s health policy over the past year.
The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
More than 1 in 5 Americans report having been threatened with a firearm, and almost as many say they worry about gun violence every day or almost every day, a new KFF poll shows.
As public health departments work on improving their message, the skepticism and mistrust often reserved for covid-19 vaccines now threaten other public health priorities, including flu shots and childhood vaccines.
Despite concerns about making abortion legal in the states and strong interest in the issue, three-quarters of Americans say economic matters are top of mind as they consider voting in the fall, according to a new KFF poll.
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
Many job-based health plans broadened their mental health and substance use coverage to make sure workers had the support they needed this year as pandemic stress lingered, the annual KFF survey finds. Also, the proportion of employers offering health insurance to their workers remained steady, and increases for premiums and out-of-pocket health expenses were moderate.
But Americans generally have little confidence that the White House or Congress will recommend the right thing, a new poll shows.
A new survey shows that unvaccinated Hispanics are almost twice as likely as unvaccinated Blacks or whites to want a covid vaccination. But many still face a variety of access problems, ranging from fear to time squeeze.
A nationwide poll released by KFF also revealed which arguments are most compelling to persuade people to get a shot — and which ones are unlikely to work.
The number of adults seeking to get inoculated has risen since December, according to a new poll.
Nearly 6 in 10 people 65 and older say they don’t have enough information about how to get vaccinated, according to a new KFF poll.
Half the public believes the worst of the pandemic is yet to come, but most are prepared to continue to take measures to limit the spread of COVID-19 until vaccines are distributed.
More than 50% of people said they favor Democratic presidential candidate Joe Biden’s approach to an array of health issues.
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
Of those who went without seeing a doctor or other medical provider, 11% experienced a worsened medical condition, according to the poll by the Kaiser Family Foundation. In addition, nearly 40% said stress related to the coronavirus crisis has negatively impacted their mental health.
The president, who has repeatedly pledged to improve health care and lower prescription drug prices, faces disapproval from a majority of Americans on his policies regarding drug costs, protecting people with preexisting conditions and the Affordable Care Act.
© 2026 KFF